Search results for " cerebrovascular disease"

showing 10 items of 11 documents

Non-coding RNAs and other determinants of neuroinflammation and endothelial dysfunction: regulation of gene expression in the acute phase of ischemic…

2021

Ischemic stroke occurs under a variety of clinical conditions and has different pathogeneses, resulting in necrosis of brain parenchyma. Stroke pathogenesis is characterized by neuroinflammation and endothelial dysfunction. Some of the main processes triggered in the early stages of ischemic damage are the rapid activation of resident inflammatory cells (microglia, astrocytes and endothelial cells), inflammatory cytokines, and translocation of intercellular nuclear factors. Inflammation in stroke includes all the processes mentioned above, and it consists of either protective or detrimental effects concerning the “polarization” of these processes. This polarization comes out from the intera…

Settore MED/09 - Medicina Internaacute phase cerebrovascular disease endothelial dysfunction epigenetics genetics neuroiflammation non-coding RNAs strokeacute phase; cerebrovascular disease; endothelial dysfunction; epigenetics; genetics; neuroiflammation; non-coding rnas; strokeInflammationReviewendothelial dysfunctionlcsh:RC346-429Proinflammatory cytokineDevelopmental NeurosciencemicroRNAMedicinegeneticsStrokelcsh:Neurology. Diseases of the nervous systemNeuroinflammationInnate immune systemepigeneticsMicrogliabusiness.industryMesenchymal stem cellacute phasemedicine.diseasestrokecerebrovascular diseasemedicine.anatomical_structureneuroiflammationnon-coding RNAsmedicine.symptombusinessNeuroscienceNeural Regeneration Research
researchProduct

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analys…

2017

People with severe mental illness (SMI) – schizophrenia, bipolar disorder and major depressive disorder – appear at risk for cardiovascular disease (CVD), but a comprehensive meta-analysis is lacking. We conducted a large-scale meta-analysis assessing the prevalence and incidence of CVD; coronary heart disease; stroke, transient ischemic attack or cerebrovascular disease; congestive heart failure; peripheral vascular disease; and CVD-related death in SMI patients (N=3,211,768) versus controls (N=113,383,368) (92 studies). The pooled CVD prevalence in SMI patients (mean age 50 years) was 9.9% (95% CI: 7.4-13.3). Adjusting for a median of seven confounders, patients had significantly higher o…

medicine.medical_specialtyCardiovascular disease; bipolar disorder; cerebrovascular disease; congestive heart failure; coronary heart disease; major depression; premature mortality; schizophrenia; severe mental illness03 medical and health sciences0302 clinical medicinesevere mental illnessMedicineCardiovascular disease severe mental illness schizophrenia bipolar disorder major depression coronary heart disease cerebrovascular disease congestive heart failure premature mortalitycoronary heart diseasePsychiatrybipolar disorderFramingham Risk Scorebusiness.industryVascular diseaseIncidence (epidemiology)Hazard ratioCorrectionOdds ratiomedicine.diseaseCardiovascular disease030227 psychiatrycerebrovascular diseaseschizophreniaPsychiatry and Mental healthcongestive heart failurepremature mortalityHeart failureMajor depressive disorderPshychiatric Mental Healthbusinessmajor depressionBody mass index030217 neurology & neurosurgery
researchProduct

Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Dise…

2020

Diabetes mellitus is a heterogeneous and dysmetabolic chronic disease in which the laboratory plays a fundamental role, from diagnosis to monitoring therapy and studying complications. Early diagnosis and good glycemic control should start as early as possible to delay and prevent metabolic and cardio-vascular complications secondary to this disease. Glycated hemoglobin is currently used as the reference parameter. The accuracy of the glycated hemoglobin dosage may be compromised in subjects suffering from chronic renal failure and terminal nephropathy, affected by the reduction in the survival of erythrocytes, with consequent decrease in the time available for glucose to attach to the hemo…

medicine.medical_specialtyobesitykidney diseaseglycated albumin cerebrovascular disease diabetes dyslipidemia obesity kidney disease therapy cardiovascular diseaselcsh:Medicine030209 endocrinology & metabolismDiseaseReview030204 cardiovascular system & hematologyNephropathy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinecardiovascular diseaseInternal medicineDiabetes mellitusMedicineGlycemictherapydiabetesbusiness.industrylcsh:RdyslipidemiaGeneral Medicinecardiovascular disease; cerebrovascular disease; diabetes; dyslipidemia; glycated albumin; kidney disease; obesity; therapymedicine.diseasecerebrovascular diseasechemistryBiomarker (medicine)glycated albuminGlycated hemoglobinbusinessDyslipidemiaKidney diseaseJournal of Clinical Medicine
researchProduct

Cognitive impairment and stroke in elderly patients.

2016

Daniele Lo Coco,1 Gianluca Lopez,1 Salvatore Corrao,2,31Neurology and Stroke Unit, 2Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, Palermo, 3Centre of Research for Effectiveness and Appropriateness in Medicine (C.R.E.A.M.), Di.Bi.M.I.S., University of Palermo, Palermo, Italy Abstract: We reviewed current knowledge about the interaction between stroke and vascular risk factors and the development of cognitive impairment and dementia. Stroke is increasingly recognized as an important cause of cognitive problems and has been implicated in the development of both Alzheimer's disease and vascular dementia. Th…

Preventive Health ServiceGerontologylcsh:Diseases of the circulatory (Cardiovascular) systemAgingEndocrinology Diabetes and MetabolismDiseaseReview0302 clinical medicineCognitionRisk FactorsPreventive Health ServicesPrevalenceMedicineAge FactorPharmacology (medical)030212 general & internal medicineCognitive declineStrokeAged 80 and overAge FactorsCognitionHematologyGeneral MedicinePrognosiscerebrovascular diseaseStrokeCardiology and Cardiovascular MedicineRisk assessmentHumanPrognosielderlyRisk AssessmentVascular risk factorAging; Cerebrovascular disease; Cognitive function; Dementia; Vascular risk factors; Age Factors; Aged; Aged 80 and over; Aging; Cognition Disorders; Geriatric Assessment; Humans; Prevalence; Preventive Health Services; Prognosis; Quality of Life; Risk Assessment; Risk Factors; Stroke; Cognition; Cardiology and Cardiovascular Medicine; Pharmacology (medical); Public Health Environmental and Occupational Health; Hematology; Endocrinology Diabetes and MetabolismCognition Disorder03 medical and health sciencesDementiaHumansCognitive rehabilitation therapyVascular dementiaGeriatric Assessmentcognitive functioncognitive impairmentAgedbusiness.industryRisk FactorPublic Health Environmental and Occupational Healthmedicine.diseaselcsh:RC666-701vascular risk factorsQuality of LifebusinessCognition Disorders030217 neurology & neurosurgerydementiaVascular health and risk management
researchProduct

Primary stroke prevention worldwide:translating evidence into action

2021

Abstract: Stroke is the second leading cause of death and the third leading cause of disability worldwide and its burden is increasing rapidly in low-income and middle-income countries, many of which are unable to face the challenges it imposes. In this Health Policy paper on primary stroke prevention, we provide an overview of the current situation regarding primary prevention services, estimate the cost of stroke and stroke prevention, and identify deficiencies in existing guidelines and gaps in primary prevention. We also offer a set of pragmatic solutions for implementation of primary stroke prevention, with an emphasis on the role of governments and population-wide strategies, includin…

Global Burden of Disease03 medical and health sciences0302 clinical medicineNursingBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Neurology.Medicine030212 general & internal medicineStrokeHealth policyCause of deathEntire populationHealth professionalsbusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Neurologija.medicine.disease3. Good healthStrokeAction (philosophy)Stroke preventionOcclusive Cerebrovascular DiseaseLife course approachHuman medicinebusiness030217 neurology & neurosurgery
researchProduct

Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke

2009

Few studies have examined the relationship between inflammatory biomarker blood levels, cardioembolic stroke subtype and neurological deficit. So the aim of our study is to evaluate plasma levels of immuno-inflammatory variables in patients with cardio-embolic acute ischaemic stroke compared to other diagnostic subtypes and to evaluate the relationship between immuno-inflammatory variables, acute neurological deficit and brain infarct volume. One hundred twenty patients with acute ischaemic stroke and 123 controls without a diagnosis of acute ischaemic stroke were evaluated. The type of acute ischaemic stroke was classified according to the TOAST classification. We evaluated plasma levels o…

MaleTOAST Classificationmedicine.medical_specialtySettore MED/09 - Medicina InternaHeart DiseasesEmbolismInterleukin-1betaSeverity of Illness IndexBrain Ischemiacytokines stroke cardioembolicCentral nervous system diseaseBrain ischemiaDisability EvaluationPredictive Value of TestsInternal medicineSeverity of illnessmedicineHumanscardiovascular diseasesStrokeAgedAged 80 and overInterleukin-6Tumor Necrosis Factor-alphaVascular diseasebusiness.industryCerebral infarctionCase-control studyHematologyMiddle Agedmedicine.diseaseSurgeryStrokeRisk Factors inflammation cytokines Stroke Cerebral infarct cerebrovascular disease cerebrovascular accidentCase-Control StudiesLinear ModelsCardiologyFemaleSettore MED/26 - NeurologiaInflammation MediatorsbusinessBiomarkers
researchProduct

New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention.

2017

Exercise training prevents the onset and the development of many chronic diseases, acting as an effective tool both for primary and for secondary prevention. Various mechanisms that may be the effectors of these beneficial effects have been proposed during the past decades: some of these are well recognized, others less. Muscular myokines, released during and after muscular contraction, have been proposed as key mediators of the systemic effects of the exercise. Nevertheless the availability of an impressive amount of evidence regarding the systemic effects of muscle-derived factors, few studies have examined key issues: (I) if skeletal muscle cells themselves are the main source of cytokin…

0301 basic medicinemedicine.medical_specialtyregular exercisemedicine.medical_treatmentInflammationBioinformaticsCachexiaCoronary artery disease03 medical and health sciencesMyokineMyokineReview Article on Myokines Exercise and Cardiovascular DiseasemedicineRehabilitationMyokines; cardiac rehabilitation; cardiovascular disease (CVD); cerebrovascular disease; regular exercisecardiovascular disease (CVD)business.industrySkeletal muscleGeneral Medicinemedicine.diseasecerebrovascular diseasecardiac rehabilitation030104 developmental biologyCytokinemedicine.anatomical_structureSarcopeniaPhysical therapymedicine.symptombusiness
researchProduct

CPK increase as an occult marker of cerebrovascular disease: a case report.

2012

CPKSettore MED/09 - Medicina InternaCPK; cerebrovascular disease;cerebrovascular disease
researchProduct

Clinical presentation of strokes confined to the insula: a systematic review of literature

2021

Abstract Background and purpose The insular cortex serves a wide variety of functions in humans, ranging from sensory and affective processing to high-level cognition. Hence, insular dysfunction may result in several different presentations. Ischemic strokes limited to the insular territory are rare and deserve a better characterization, to be quickly recognized and to receive appropriate treatment (e.g. thrombolysis). Methods We reviewed studies on patients with a first-ever acute stroke restricted to the insula. We searched in the Medline database the keywords “insular stroke” and “insular infarction”, to identify previously published cases. Afterwards, the results were divided depending …

Malemedicine.medical_specialtyNeurologySensory systemReview ArticleDermatology030204 cardiovascular system & hematologyInsular cortexbehavioral disciplines and activities03 medical and health sciencesDysarthria0302 clinical medicinePhysical medicine and rehabilitationAphasiaAphasiamedicineHumansSpeechCerebrovascular diseaseStrokeNeuroradiologyInsular syndromesCerebral CortexInsular stroke Insular dysfunction Insular syndromes Cerebrovascular diseasebusiness.industryDysarthriaGeneral Medicinemedicine.diseaseStrokePsychiatry and Mental healthnervous systembehavior and behavior mechanismsInsular strokeSettore MED/26 - NeurologiaFemaleNeurology (clinical)medicine.symptomInsular dysfunctionbusinessInsulapsychological phenomena and processes030217 neurology & neurosurgeryNeurological Sciences
researchProduct

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRI…

2022

Objective: Post-stroke epilepsy (PSE) is one of the most common causes of acquired epilepsy and accounts for about 10-15% of all newly diagnosed epilepsy cases. However, evidence about the clinical profile of antiseizure medications in the PSE setting is currently limited. Brivaracetam (BRV) is a rationally developed compound characterized by high-affinity binding to synaptic vesicle protein 2A. The aim of this study was to assess the 12-month effectiveness and tolerability of adjunctive BRV in patients with PSE treated in a real-world setting. Methods: This was a subgroup analysis of patients with PSE included in the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST). The BRIVAFI…

AdultAntiseizure medication; Brivaracetam; Cerebrovascular diseases; Focal seizures; StrokeCerebrovascular diseasesSettore MED/26Antiseizure medication Brivaracetam Focal seizures Stroke Cerebrovascular diseasesFocal seizuresDouble-Blind MethodDrug TherapySeizuresHumansAgedRetrospective StudiesAntiseizure medicationEpilepsyGeneral MedicineMiddle AgedPyrrolidinonesStrokeTreatment OutcomeNeurologyItalyCombinationBrivaracetamAntiseizure medication; Brivaracetam; Cerebrovascular diseases; Focal seizures; Stroke; Adult; Aged; Anticonvulsants; Double-Blind Method; Drug Therapy Combination; Humans; Italy; Middle Aged; Pyrrolidinones; Retrospective Studies; Seizures; Treatment Outcome; Epilepsy; StrokeDrug Therapy CombinationAnticonvulsantsNeurology (clinical)
researchProduct